Literature DB >> 150826

Sclerosing peritonitis and propranolol.

R F Harty.   

Abstract

Sclerosing peritonitis developed in a 43-year-old man with angina pectoris who had been receiving the beta-adrenergic receptor antagonist, propranolol. The patient had abdominal and back pain, weight loss, a midabdominal fullness, ascites, and evidence of partial small bowel obstruction. At surgery, the small bowel was distended and encased by dense fibrous tissue. Infectious and neoplastic causes of fibrosing peritoneal inflammation were excluded. The patient described in this report illustrates several features commonly experienced by individuals who developed sclerosing peritonitis associated with beta-adrenergic receptor blockade therapy. To my knowledge, the development of ascites and considerable ascitic fluid leukocytosis have not been described previously with this disorder.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 150826

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

1.  Sclerosing encapsulating peritonitis.

Authors:  M Wanic-Kossowska; A Grzegorzewska; H Płotast
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

2.  Sclerosing peritonitis.

Authors:  R G Lee
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

3.  Propranolol, oxprenolol, and sclerosing peritonitis.

Authors:  J H Marigold; R E Pounder; J Pemberton; R P Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-20

Review 4.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

Review 5.  Successful delivery after IVF-ET in an abdominal cocoon patient: case report and literature review.

Authors:  Dan Hu; Rui Wang; Ting Xiong; Han Wang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

6.  Sclerosing encapsulating peritonitis in a long-term propranolol user.

Authors:  Se Hui Noh; Byong Duk Ye; Hoonsub So; Yu Seok Kim; Dong Jin Suh; Sang Nam Yoon
Journal:  Intest Res       Date:  2016-10-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.